Nano Holdings, Inc. (TYO:4571)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2010	Mar 31, 2009	Mar 31, 2008	Mar 31, 2007	Mar 31, 2006
Research and Development of Pharmaceutical Products		108.00M	135.00M	202.00M	117.82M	353.65M
Research and Development of Pharmaceutical Products Growth		-20.00%	-33.17%	71.45%	-66.68%	-
Total		108.00M	135.00M	202.00M	117.82M	353.65M
Total Growth		-20.00%	-33.17%	71.45%	-66.68%	-

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2010	Mar 31, 2009	Mar 31, 2008	Mar 31, 2007	Mar 31, 2006
Japan		108.00M	135.51M	153.40M	117.82M	353.65M
Japan Growth		-20.30%	-11.67%	30.20%	-66.68%	-
Taiwan		-	-	48.79M	-	-
Total		108.00M	135.51M	202.19M	117.82M	353.65M
Total Growth		-20.30%	-32.98%	71.61%	-66.68%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 11, 2026

Data Sources Report a data error